Barclays
STTK icon

Barclays’s Shattuck Labs STTK Stock Holding History

Barclays’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$771K Buy
+119,879
New +$569K ﹤0.01% 2914
2025
Q3 		– Sell
-2,114
Closed -$1.67K – 5721
2025
Q2 		$1.67K Sell
2,114
-48,771
-96% -$47.3K ﹤0.01% 5047
2025
Q1 		$48.3K Sell
50,885
-10,106
-17% -$12.5K ﹤0.01% 4620
2024
Q4 		$73.8K Buy
60,991
+6,680
+12% +$8.28K ﹤0.01% 4658
2024
Q3 		$190K Buy
54,311
+40,717
+300% +$152K ﹤0.01% 4331
2024
Q2 		$52.5K Buy
13,594
+13,402
+6,980% +$109K ﹤0.01% 4192
2024
Q1 		$1.72K Buy
+192
New +$1.76K ﹤0.01% 4922
2023
Q4 		– Sell
-16,471
Closed -$25K – 5343
2023
Q3 		$25K Hold
16,471
– – ﹤0.01% 4121
2023
Q2 		$51.4K Hold
16,471
– – ﹤0.01% 3821
2023
Q1 		$48.4K Hold
16,471
– – ﹤0.01% 4459
2022
Q4 		$37.9K Hold
16,471
– – ﹤0.01% 4646
2022
Q3 		$44K Sell
16,471
-39
-0.2% -$146 ﹤0.01% 3818
2022
Q2 		$67K Sell
16,510
-4,350
-21% -$15.8K ﹤0.01% 3934
2022
Q1 		$88K Buy
+20,860
New +$118K ﹤0.01% 3847

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Barclays's STTK Position: Q1 2026 in Review

Barclays opened a new position in Shattuck Labs (STTK) in Q1 2026: 119,879 shares worth $771K. The stake represents ﹤0.01% of the portfolio and ranks #2914 among its holdings. This is a return to the name: Barclays previously reported a position in STTK as recently as Q2 2025.

Barclays first reported a position in STTK in Q1 2022 and has held it in 14 quarters since. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Barclays held 119,879 shares of Shattuck Labs worth $771K as of Q1 2026.
  • Shattuck Labs was a new Barclays position in Q1 2026.
  • Shattuck Labs made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2914 holding.
  • Barclays first reported a position in Shattuck Labs in Q1 2022 and has held it in 14 quarters since.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.